NL-OMON41218已完成不适用
Development and validation of a humanized mouse psoriasis model to be applied for efficacy analysis of novel therapeutic compounds - Development and validation of a pre-clinical psoriasis model
TNO Triskelion0 个研究点目标入组 6 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Adult Psoriasis patients, m/f, with a mild to moderate form of psoriasis vulgaris, i.e. a maximal PASI score of 18 and a minimum BSA of 3%. Patients are allowed to use local corticosteroids or ointments to prevent dry skin (see Appendix 2).
排除标准
- •Psoriasis patients have NOT received light therapy or another form of SYSTEMIC treatment (e.g. treatment with methotrexate, cyclosporin A or anti-TNF). Gender or age of the adult patients are no exclusion criteria (see Appendix 2).
研究者
相似试验
暂停
不适用
Generation of humanaized mice by using human PBMC and their applications for researchhealthy volunteerJPRN-UMIN000008799Osaka University Graduate School of Medicine200
已完成
不适用
The development and validation of models of human skin diseases for drug testingatopic dermatitisDeveloping human skin disease modelspsoriasisvitiligo10047043NL-OMON38558Derphartox36
已完成
不适用
Efficacy of MT204 in a humanized mouse model of psoriasis - Module 2flaking diseasepsoriasis1000381610014982NL-OMON34174Micromet AG24
进行中（未招募）
不适用
Integrated Genomics and Avatar Mouse Models for Personalized Treatment of Pancreatic CancerEUCTR2015-004860-12-ESCentro Nacional Investigaciones Oncológicas (CNIO)
已完成
不适用
Clinical skills assessment of a humanoid robot healthcare providerPerceptions of robot healthcare deliveryACTRN12617000724370Dr. Balaji Bikshandi30